Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0009443 (
cold
)
92,137
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
L-Dihydroxphenylalanine (L-DOPA) significantly inhibited intrathyroidal colloid droplet formation induced by exposure to
cold
in the rat. Diethyldithiocarbamate (DDC) also inhibited colloid droplet formation in response to
cold
. The combined administration of L-DOPA and DDC produced an additive inhibition of the thyroidal endocytotic response to exposure to
cold
. Pretreatment with chlorpromazine (CPZ) ameliorated the inhibitory effect of L-DOPA. DL-alpha-methyl-p-tyrosine (alpha-MT) also signficantly depressed the thyroidal response. Inhibition of colloid droplet formation induced by alpha-MT was not altered by the administration of DL-dihydroxyphenylserine (DL-DOPS). On the other hand, treatment of the alpha-MT-treated rats with L-DOPA to normalize dopamine synthesis resulted in a dramatic recovery from the inhibition. Blockade of serotonin biosynthesis with p-chlorophenylalanine (p-CPA) failed to produce a significant inhibition of colloid droplet formation. However, 5-hydroxytryptophan (5-HTP) markedly inhibited the thyroidal response to
cold
.
Brocresine
phosphate (BP) was another inhibitor of the thyroidal endocytotic response to exposure to
cold
. Oxotremorine also markedly depressed the thyroidal response to
cold
. Since these drugs did not interfere with pituitary thyroid responsiveness to exogenous thyrotropin-releasing hormone (TRH), it seems that the throidal endocytotic response to exposure to
cold
as a reflection of TSH secretion was directly influenced by alterations of brain biogenic amine concentrations or turnover rates.
...
PMID:Effects of drugs that modify brain biogenic amine concentrations on thyroid activation induced by exposure to cold. 18 Apr 45